MUMBAI, March 8 - Indian drugmaker Ranbaxy Laboratories Ltd, reeling under a flurry of regulatory rebukes due to poor quality, has recalled more than 64,000 bottles of the generic version of a cholesterol-lowering drug in the United States after doseage mix-up was detected.
March 7 - Indian drug maker Ranbaxy Laboratories Ltd has recalled more than 64,000 bottles of the generic versions of its cholesterol-lowering drug in the United States due to reports of a dose mix-up, U.S. regulators said.
NEW HAVEN, Conn., March 7 - A federal jury on Friday found former Jefferies Group Inc trader Jesse Litvak guilty of defrauding clients on mortgage bond trades made after the financial crisis.
WASHINGTON, March 7 - An update of a pivotal report on U.S. liquefied natural gas exports released on Friday found that allowing unlimited shipments of gas abroad would benefit the U.S. economy, mirroring the findings of the initial study.
March 7 - The U.S. Food and Drug Administration has asked Regeneron Pharmaceuticals Inc and Sanofi SA to assess potential neurocognitive side effects of their experimental cholesterol drug, Sanofi said in its annual report on Friday.
WASHINGTON, March 7 - The Obama administration said on Friday Verizon Communications Inc's Terremark unit will remain under contract as host of the federal website HealthCare.gov to better ensure a smooth end to Obamacare's open enrollment period on March 31.
NEW YORK, March 7 - Energy Transfer Partners on Friday announced plans to build an oil pipeline from the Bakken shale in North Dakota to U.S. Midwest and Gulf Coast refineries, seeking support for a major new conduit even after rivals dropped similar plans.
NEW YORK, March 7 - Energy Transfer Partners on Friday announced plans to build a pipeline that would transport oil from the Bakken shale in North Dakota to multiple refineries in the Midwest and Gulf Coast regions.
March 7 - A whistleblower will be paid $63.9 million for providing tips that led to JPMorgan Chase & Co's agreement to pay $614 million and tighten oversight to resolve charges that it defrauded the government into insuring flawed home loans.
March 7 - The U.S. Food and Drug Administration has asked Regeneron and Sanofi to assess potential neurocognitive side effects of their experimental cholesterol drug, Sanofi said in its annual report on Friday.
- Financial: BRIEF-U.S. jury finds former Jefferies trader Litvak guilty of fraud
- Technology: Mexican tycoon Slim's Grupo Carso designated 'dominant' in telecoms
- Healthcare: CORRECTED-FEATURE-New hemophilia drugs aim to simplify treatment
- Consumer: UK court ruling may prompt more scrutiny of Amazon tax plans
- Energy: RPT-CERAWEEK-Severe U.S. winter opens door to questions for gas, power markets
- Industrials: REFILE-Car coolant rejected by Daimler is safe, say EU scientists
- M&A: RPT-Be inspired by risk, HSBC's Blyth tells female financiers
- Bankruptcy: Spain struggles to pull together multibillion euro highway bail-out
- IPOs: UPDATE 1-Rolls-Royce to buy Daimler stake of power systems unit with cash, borrowing
- Private Capital: KKR retail investing chief has left company
- Hedge Funds: Computer-driven trade to grab market share in 2014
- Malaysia Airlines denies crash report, says plane still missing |
- Ukraine standoff intensifies; Russia says sanctions will 'boomerang' |
- U.S. job growth offers upbeat sign for weather-beaten economy |
- Republicans gain momentum in close fight for U.S. Senate
- China draws red line' on North Korea, says won't allow war on peninsula
- Boeing reports wing cracks on 787 Dreamliners in production
- Three killed in Cairo clashes, 48 wounded across Egypt
- Suspected Russian spyware Turla targets Europe, United States
- Iran, world powers hold 'substantive and useful' nuclear talks
- Netanyahu says Israel would give up 'some settlements' for peace